12 Safe Stocks to Buy for the Long Term in 2025

Page 1 of 12

In this article, we discuss the 12 safe stocks to buy for the long term in 2025.

The US stock market is often regarded as one of the most reliable and resilient financial markets in the world. With its deep liquidity, broad participation, and historical ability to recover from downturns, it has long been a cornerstone of wealth creation for individual and institutional investors. While it is subject to short-term volatility, its long-term performance and structural advantages make it a reliable platform for investment. It has a proven track record of delivering strong returns over the long term. The S&P 500, a benchmark index that represents the performance of 500 large-cap US companies, has averaged an annual return of approximately 10% since its inception in 1926. While short-term fluctuations are inevitable, the market’s historical trajectory has been one of growth, driven by corporate innovation, economic expansion, and rising consumer demand.

Read more about these developments by accessing 10 Best AI Data Center Stocks and 10 Buzzing AI Stocks According to Goldman Sachs.

During major crises such as the Great Depression, the 2008 financial crisis, and the COVID-19 pandemic, the market experienced sharp declines but eventually rebounded to new highs. For example, after the COVID-19 crash in March 2020, the S&P 500 recovered within six months and went on to hit record levels, underscoring its resilience. One of the key factors contributing to the reliability of the US stock market is its breadth and diversity. The market includes a wide array of industries, from technology and health care to consumer goods and energy, allowing investors to diversify their portfolios to reduce risk. Additionally, US exchanges like the New York Stock Exchange and Nasdaq are among the most liquid in the world, making it easy for investors to buy and sell shares efficiently. This liquidity and diversification provide a level of stability that is unmatched in many other markets, offering investors confidence in the market’s ability to withstand shocks and recover from volatility.

Read more about these developments by accessing 30 Most Important AI Stocks According to BlackRock and Beyond the Tech Giants: 35 Non-Tech AI Opportunities.

For this article, we selected stocks that have solid businesses with recurring revenue streams, reliable dividend payouts, and burgeoning growth pipelines. These stocks are also popular among hedge funds. Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 275% since May 2014, beating its benchmark by 150 percentage points (see more details here).

12 Safe Stocks to Buy for the Long Term in 2025

Stocks chart

Safe Stocks to Buy for the Long Term in 2025

12. Bristol-Myers Squibb Company (NYSE:BMY)

Number of Hedge Fund Holders: 70 

Bristol-Myers Squibb Company (NYSE:BMY) is a New York-based pharmaceutical company. This company stands out as a worthwhile investment due to various compelling reasons. To begin, the company has shown strong performance in dividend growth, with 8 consecutive years of increases, surpassing the sector median of 2 years by 300%. In addition, the company has also maintained 35 consecutive years of dividend payments, outperforming the sector median of 15 years by 133%. These metrics reflect the company’s ability to deliver valuable returns to shareholders and its strong financial health. Lastly, the company and Cellares have announced a worldwide capacity reservation and supply agreement for the manufacture of CAR T cell therapies in a transaction valued at up to $380 million in upfront and milestone payments. This agreement would strengthen Bristol Myers Squibb’s existing global network of state-of-the-art cell therapy manufacturing facilities and provide increased agility, improved scalability and potential to improve turnaround time to support the company’s CAR T inline and pipeline assets.

Page 1 of 12